Search alternatives:
"program improvements" » "process improvement" (Expand Search), "term improvements" (Expand Search)
"program implementing" » "from implementing" (Expand Search)
"program implementingrules" » "from implementingrules" (Expand Search)
Showing 181 - 200 results of 529 for search '(((("program improvements") OR ("program implementing"))) OR ("program implementingrules"))', query time: 0.26s Refine Results
  1. 181
    Japanese encephalitis expected and observed cases and incidence rates (IR) per 100,000 person years in Nepal.

    Japanese encephalitis expected and observed cases and incidence rates (IR) per 100,000 person years in Nepal. by Shyam Raj Upreti (4451614)

    Published 2017
    Subjects:
    Save to List
    Saved in:
  2. 182
    Japanese encephalitis expected and observed cases and incidence rates (IR) per 100,000 person years by age group in Nepal.

    Japanese encephalitis expected and observed cases and incidence rates (IR) per 100,000 person years by age group in Nepal. by Shyam Raj Upreti (4451614)

    Published 2017
    Subjects:
    Save to List
    Saved in:
  3. 183
    Percent difference in expected and observed incidence of Japanese encephalitis following vaccination campaign, by district, Nepal.

    Percent difference in expected and observed incidence of Japanese encephalitis following vaccination campaign, by district, Nepal. by Shyam Raj Upreti (4451614)

    Published 2017
    Subjects:
    Save to List
    Saved in:
  4. 184
    Characteristics of confirmed invasive pneumococcal disease cases reported in Ontario, Canada, 2007–2017 (N = 12,377).

    Characteristics of confirmed invasive pneumococcal disease cases reported in Ontario, Canada, 2007–2017 (N = 12,377). by Shinthuja Wijayasri (8124539)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  5. 185
    Incidence rates (per 100,000 population) of invasive pneumococcal disease, by year, associated vaccine type<sup>a</sup> and age group, in Ontario, Canada, 2007-2017<sup>b</sup>.

    Incidence rates (per 100,000 population) of invasive pneumococcal disease, by year, associated vaccine type<sup>a</sup> and age group, in Ontario, Canada, 2007-2017<sup>b</sup>. by Shinthuja Wijayasri (8124539)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  6. 186
    Incidence rates (per 100,000 population) of invasive pneumococcal disease, by age group and year, in Ontario, Canada, 2007–2017.

    Incidence rates (per 100,000 population) of invasive pneumococcal disease, by age group and year, in Ontario, Canada, 2007–2017. by Shinthuja Wijayasri (8124539)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  7. 187
    Serotype distribution of invasive pneumococcal disease cases<sup>a</sup>, by associated vaccine type, in Ontario, Canada, 2007–2017.

    Serotype distribution of invasive pneumococcal disease cases<sup>a</sup>, by associated vaccine type, in Ontario, Canada, 2007–2017. by Shinthuja Wijayasri (8124539)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  8. 188
    Number of confirmed invasive pneumococcal disease cases, by associated vaccine type<sup>a</sup> and year, in Ontario, Canada, 2007–2017 (N = 12,377).

    Number of confirmed invasive pneumococcal disease cases, by associated vaccine type<sup>a</sup> and year, in Ontario, Canada, 2007–2017 (N = 12,377). by Shinthuja Wijayasri (8124539)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  9. 189
    Incidence rates (per 100,000 population) of commonly<sup>a</sup> reported <i>S</i>. <i>pneumoniae</i> serotypes in Ontario, Canada, by year: 2007–2017.

    Incidence rates (per 100,000 population) of commonly<sup>a</sup> reported <i>S</i>. <i>pneumoniae</i> serotypes in Ontario, Canada, by year: 2007–2017. by Shinthuja Wijayasri (8124539)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  10. 190
    VIA findings at first screening by age, lesion severity, and HIV status in Namibia (October 2018–March 2020).

    VIA findings at first screening by age, lesion severity, and HIV status in Namibia (October 2018–March 2020). by Abigail K. Korn (12096012)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  11. 191
    Same day cryotherapy/thermocoagulation performed by HIV status in Namibia (October 2018 –March 2020).

    Same day cryotherapy/thermocoagulation performed by HIV status in Namibia (October 2018 –March 2020). by Abigail K. Korn (12096012)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  12. 192
    Treatment for cervical pre-cancer lesions and post-treatment complications by age, lesion severity, and HIV status in Namibia (October 2018–March 2020).

    Treatment for cervical pre-cancer lesions and post-treatment complications by age, lesion severity, and HIV status in Namibia (October 2018–March 2020). by Abigail K. Korn (12096012)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  13. 193
    Participant demographics.

    Participant demographics. by Nickolas D. Zaller (8727462)

    Published 2020
    Subjects:
    Save to List
    Saved in:
  14. 194
    Characteristics of participants at baseline of community ART group.

    Characteristics of participants at baseline of community ART group. by Patrick Dakum (364901)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  15. 195
    Summary of council demographics and geography.

    Summary of council demographics and geography. by Castory Munishi (9308105)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  16. 196
    Total cost of referrals completed for FY2020/21.

    Total cost of referrals completed for FY2020/21. by Castory Munishi (9308105)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  17. 197
    The decision tree comparing the cost and effectiveness of the standard referral system and the emergency transport system.

    The decision tree comparing the cost and effectiveness of the standard referral system and the emergency transport system. by Castory Munishi (9308105)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  18. 198
    Differences in the participants’ bodyweight, immunologic and virologic status after a year follow-up.

    Differences in the participants’ bodyweight, immunologic and virologic status after a year follow-up. by Patrick Dakum (364901)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  19. 199
    Summary of test results after one year of follow-up.

    Summary of test results after one year of follow-up. by Patrick Dakum (364901)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  20. 200
    Mean of completed referrals for FY 2020/2021.

    Mean of completed referrals for FY 2020/2021. by Castory Munishi (9308105)

    Published 2023
    Subjects:
    Save to List
    Saved in:

Search Tools: